Navigation Links
Inovio Pharmaceuticals to Present at Noble Financial Life Sciences Conference
Date:9/18/2012

BLUE BELL, Pa., Sept. 18, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today  that J. Joseph Kim, Ph.D., President and CEO, will present and participate in a panel at BIOX, Noble Financial Capital Markets' Life Sciences Exposition to be held at the University of Connecticut, Stamford Campus on September 24-25, 2012.

Inovio Presentation
Monday, September 24
3:00 PM ET

Panel Presentation
Monday, September 24
5:55 PM ET
"Innovation in Immunotherapy & Vaccines"

Following the event, a high-definition video webcast of the presentation will be available on Inovio's website. It will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast will be archived on Inovio's website for 90 days following the event.

About Inovio Pharmaceuticals, Inc.

Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynCon® vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile. Inovio's clinical programs include Phase II studies for cervical dysplasia, leukemia and hepatitis C virus and Phase I studies for influenza and HIV. Partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, US Dept. of Homeland Security and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-loo
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Inovios Scientific Advisory Board Chairman Elected as a Fellow by the American Association for the Advancement of Science
2. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
3. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
4. MD Anderson Cancer Center joins Actinium Pharmaceuticals (API) Multicenter Actimab-A Trial
5. Lexicon Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
6. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
7. Isis Pharmaceuticals To Present At Two Upcoming Investor Conferences
8. Onyx Pharmaceuticals To Present At Upcoming Investor Conferences
9. Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org
10. Inspiration Biopharmaceuticals Announces New Global Commercialization Agreements with Ipsen
11. Mangrove Partners Sends Letter to Stockholders of Nabi Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 This is a professional ... M-Phenylenediamine (mPDA) industry in Global and China. The ... definitions, applications and industry chain structure. Global market analysis ... focus on history, developments, trends and competitive landscape of ... situation is also offered. , The report also focuses ...
(Date:9/22/2014)... Research and Markets has announced ... Cellulose Industry Report 2014" report to their offering. ... Industry Report 2014 is a professional and in-depth study ... industry with a focus on the Chinese situation. ... industry including definitions, classifications, applications and industry chain structure. ...
(Date:9/22/2014)...  WIRB-Copernicus Group (WCG), the world,s largest provider ... research, announced today that its Western Institutional Review ... the Association for the Accreditation of Human Research ... for clinical research participants. WCG Chairman ... commented, "It is of utmost importance to WCG ...
(Date:9/21/2014)... Switzerland have succeeded in observing the "forbidden" infrared ... time. These extremely weak spectra offer perspectives for ... also contribute to the development of molecular clocks ... the scientific journal Nature Physics . , ... and light, is probably the most important method ...
Breaking Biology Technology:m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Uncovering the forbidden side of molecules 2
... May 29 Sangamo BioSciences,Inc. (Nasdaq: SGMO ... CEO, will provide an update on Sangamo,s diabetic ... 6, 2008, at the Canaccord Adams,Diabetes and Obesity ... be webcast live and may be accessed via ...
... 29 Diplomat Specialty,Pharmacy, a leader in specialty ... (DTM) announced today that their specialty,pharmacy was one ... Roundtable,(NMCRT) held this month in Dallas, Texas. This ... managed care organizations together to,review and improve on ...
... NanoBio(R) Corporation, a,biopharmaceutical company focused on developing ... of infectious diseases, today,announced the appointment of David ... most recently served as President of Pharmaceutical Operations ... David to our Board of Directors and look,forward ...
Cached Biology Technology:Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference 2Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board 2David M. Stout Joins NanoBio Corporation's Board of Directors 2
(Date:9/21/2014)... autism are significantly less likely to report taking iron ... of children who are developing normally, a study by ... , Low iron intake was associated with a five-fold ... mother was 35 or older at the time of ... conditions such as obesity hypertension or diabetes. , The ...
(Date:9/21/2014)... MA -- In recent years, new strains of bacteria ... Each year, these superbugs, including drug-resistant forms of tuberculosis ... and kill at least 23,000. Despite the urgent need ... classes of antibiotics in the past decade. , MIT ... these superbugs. Using a gene-editing system that can disable ...
(Date:9/19/2014)... Jimmy Durante of dinosaurs a newly discovered ... new dinosaur, named Rhinorex condrupus by ... Young University, lived in what is now Utah ... Cretaceous period. , Rhinorex, which translates roughly into ... relative of other Cretaceous hadrosaurs like Parasaurolophus and ...
Breaking Biology News(10 mins):Mothers of children with autism less likely to have taken iron supplements 2Battling superbugs 2Battling superbugs 3Battling superbugs 4New hadrosaur noses into spotlight 2
... in New Guinea, one of which is the new smallest known ... issue of the online journal PLoS ONE , and the ... University. The new smallest vertebrate species is called Paedophryne ... it was found. The adult body size for these frogs ranges ...
... gene 15 (ISG15), a ubiquitin like protein, is highly ... How the elevated ISG15 pathway contributes to tumorigenic phenotypes ... published in the January 2012 issue of Experimental ... her co-investigators from the Louisiana State University School of ...
... humans arrive in Europe and Asia? At what rate have ... How did Neanderthal teeth and bones differ from ours? These ... Max Planck Weizmann Institute of Science Center in the ... the establishment of the Center is being signed today at ...
Cached Biology News:ISG15: A novel therapeutic target to slow breast cancer cell motility 2Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology 2Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology 3Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology 4
Mouse monoclonal [SIT-01] to SIT ( Abpromise for all tested applications). entrezGeneID: 27240 SwissProtID: Q9Y3P8...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Biology Products: